Adulteration / Refusal Policy
A legal disclaimer
Effective Date: [06/21/2026]
Last Updated: [06/21/2026]
1. Purpose
This Adulteration and Refusal to Test Policy establishes the procedures followed by Battle Tested Specimen Collections when a donor attempts to adulterate a specimen or refuses to participate in the drug testing process. This policy protects the integrity of the collection process, ensures compliance with DOT and Non-DOT regulations, and defines the Collector's role and limitations in these situations. This policy applies to all DOT and Non-DOT collections performed by Battle Tested Specimen Collections.
2. Definitions
Adulteration — The addition of a substance to a specimen that is not expected to be present in human urine and that interferes with one or more drug tests or specimen validity tests. Examples include bleach, soap, vinegar, peroxide, nitrites, and commercially available adulterant products.
Substitution — The replacement of a donor's own specimen with a substance that is not consistent with normal human urine. A substituted specimen has a creatinine concentration below 2 mg/dL and a specific gravity below 1.001 or above 1.020.
Dilution — A specimen with a creatinine concentration greater than 2 mg/dL but less than 20 mg/dL and a specific gravity greater than 1.001 but less than 1.003. Dilution may be intentional or the result of excessive fluid intake.
Refusal to Test — Any action or inaction by a donor that prevents the completion of a valid drug test. Under DOT regulations a refusal to test carries the same consequences as a verified positive result.
Shy Bladder — A condition in which a donor is unable to provide a sufficient urine specimen. Shy bladder is not a refusal to test unless the donor fails to provide a specimen within the required 3-hour waiting period without a valid medical explanation.
3. What Constitutes a Refusal to Test
Under 49 CFR Part 40 and applicable Non-DOT protocols the following actions constitute a refusal to test:
Explicit Refusals:
— Verbally refusing to provide a specimen
— Refusing to sign the chain of custody form
— Refusing to cooperate with the collection process in a way that prevents completion
— Refusing to undergo an observed collection when required by regulation
— Refusing to provide a second specimen when directed after a temperature discrepancy
— Leaving the collection site before the collection process is complete without authorization
Conduct-Based Refusals:
— Providing a specimen that is verified as adulterated or substituted by the laboratory and MRO
— Failing to provide a sufficient specimen within 3 hours during shy bladder protocol without a valid medical explanation
— Attempting to use a device to interfere with the collection process
— Behaving in a manner that clearly indicates an attempt to falsify the test
Note: The Collector does not make a final determination of refusal based on laboratory findings. Laboratory-based refusals are determined by the MRO.
4. Collector's Role — What We Do and Do Not Do
It is critical to understand the Collector's limited role in adulteration and refusal situations:
The Collector DOES:
— Document all observations accurately and completely on the CCF
— Follow established DOT and laboratory protocols for each situation
— Remain professional, calm, and non-confrontational at all times
— Notify the employer or requesting party of the collection outcome
— Submit all documentation to the laboratory and MRO as required
The Collector DOES NOT:
— Accuse a donor of adulteration, substitution, or cheating
— Make a final determination that a specimen is adulterated or substituted
— Make a final determination that a donor has refused to test based on laboratory findings
— Detain a donor against their will
— Argue with or confront a donor who refuses to test
— Disclose the collection outcome to unauthorized parties
5. Adulteration Protocol
When the Collector observes indicators of potential adulteration during the collection process the following steps are taken:
Step 1 — Observe and Document
The Collector documents all specific observations on the CCF immediately including:
— Unusual specimen color, clarity, or odor
— Abnormal adulterant test results (oxidants, pH, creatinine on 13 Panel cup)
— Specimen temperature outside the 90°F to 100°F range
— Behavioral indicators observed during the collection
Step 2 — Remain Professional
The Collector does not accuse the donor of adulteration. The Collector informs the donor in a neutral, non-accusatory manner that a specimen validity concern has been noted and that the specimen will be forwarded to the laboratory for validity testing.
Step 3 — Secure the Specimen
The Collector immediately secures the specimen and completes the chain of custody documentation. The specimen is sealed and packaged for laboratory submission.
Step 4 — Second Specimen Under Observation
If the testing protocol permits and the Collector has reasonable suspicion of adulteration the Collector may request that the donor provide a second specimen under direct observation. The donor may accept or decline.If the donor accepts — both specimens are sent to the laboratory with full documentation.
If the donor declines — the original specimen is sent to the laboratory with the adulteration concern fully documented.
Step 5 — Notify
The Collector notifies the employer or requesting party that the collection has been completed with a specimen validity concern noted. The Collector does not characterize the result as a positive or a failure — that determination is made by the laboratory and MRO.
Step 6 — Laboratory Submission
The specimen is submitted to the laboratory with all CCF documentation. The laboratory performs specimen validity testing and reports findings to the MRO. The MRO makes the final determination and reports to the employer.
6. Refusal to Test Protocol
When a donor refuses to participate in or complete the collection process the Collector follows this protocol:
Step 1 — Attempt to Resolve
The Collector calmly explains the collection process and the consequences of refusing to test. The Collector makes one reasonable attempt to encourage the donor to proceed with the collection.
Step 2 — Document the Refusal
If the donor continues to refuse the Collector documents the following on the CCF:
— The date, time, and location of the refusal
— The specific nature of the refusal — what the donor said or did
— The Collector's response
— Names of any witnesses present
Step 3 — Do Not Detain
The Collector does not attempt to physically detain, block, or prevent the donor from leaving. If the donor leaves the collection site the departure time is documented on the CCF.
Step 4 — Complete the CCF
The Collector completes all available sections of the CCF and notes the refusal in the remarks section. The CCF is signed and dated by the Collector.
Step 5 — Notify the Employer
The Collector contacts the employer or requesting party as soon as reasonably possible to report that the collection was not completed due to donor refusal. The Collector provides the documented facts without characterizing the situation as a confirmed positive or drawing conclusions about the donor's intent.
Step 6 — Submit Documentation
The completed CCF documenting the refusal is submitted to the laboratory and MRO as directed. The MRO makes the final determination and reports to the employer in accordance with DOT or Non-DOT protocol.
7. Shy Bladder Protocol
Shy bladder is not a refusal to test. If a donor is unable to provide a sufficient specimen the Collector follows the DOT shy bladder protocol:
Step 1 — Discard Initial Attempt
If the donor provides less than 45 mL of urine the specimen is discarded in the presence of the donor. This is not documented as a refusal.
Step 2 — Hydration Period
The donor is permitted up to 40 ounces of fluid over a period of up to 3 hours to attempt to provide an adequate specimen. The Collector or a designated representative monitors the donor during this period.
Step 3 — Second Attempt
The donor is given another opportunity to provide a specimen. If the second attempt produces at least 45 mL the collection proceeds normally.
Step 4 — Three Hour Limit
If the donor is unable to provide an adequate specimen within 3 hours the collection is terminated. This is documented on the CCF as a failure to provide rather than a refusal to test.
Step 5 — Medical Evaluation
For DOT collections the employer must direct the donor to obtain a medical evaluation within 5 business days to determine whether a legitimate medical condition prevented specimen provision. The MRO makes the final determination.Shy Bladder Fee: A $75.00 extended wait fee applies to collections requiring the shy bladder protocol due to the additional time required of the Collector.
8. Consequences of Refusal to Test
Battle Tested Specimen Collections informs donors and employers of the following consequences of a refusal to test under DOT regulations. These are not determinations made by the Collector — they are regulatory consequences administered by the MRO and employer:
DOT Consequences:
— A refusal to test is treated the same as a verified positive result
— The donor is immediately removed from safety-sensitive functions
— The donor must complete the return-to-duty process including SAP evaluation before returning to safety-sensitive work
— The refusal is reported to the Drug and Alcohol Clearinghouse (FMCSA regulated industries)
Non-DOT Consequences:
— Consequences are determined by the employer's drug-free workplace policy
— Battle Tested Specimen Collections reports the refusal to the employer and does not determine employment consequences
9. Documentation & Record Retention
All adulteration concerns and refusal to test events are documented thoroughly and retained in accordance with the following schedule:
Adulteration documentation
5 years
Refusal to test documentation
5 years
Shy bladder documentation
5 years
Observed collection documentation
5 years
Records are stored securely and are accessible only to authorized personnel including the donor, the employer of record, the laboratory, the MRO, and regulatory authorities with proper authorization.
10. Non-Retaliation
Battle Tested Specimen Collections does not tolerate retaliation against any donor for exercising their rights during the collection process including the right to refuse to test. Donors who refuse to test will be treated with dignity and respect throughout the interaction. Consequences of refusal are regulatory in nature and administered by the employer and MRO — not by Battle Tested Specimen Collections.
11. Regulatory Compliance
This policy complies with:
— 49 CFR Part 40 — DOT Procedures for Transportation Workplace Drug and Alcohol Testing Programs
— HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs
— SAMHSA specimen validity testing requirements
— FMCSA Drug and Alcohol Clearinghouse reporting requirements
— Washington State applicable drug testing regulations
12. Contact Us
For questions about this policy or to report a concern regarding a collection please contact us:
Battle Tested Specimen Collections
DBA of Battle Tested LLC
14900 Interurban Ave. S
Suite 271 #10005
Tukwila, WA 98168
📞 (206) 939-0335
📧 info@battletestedwa.com
🌐 www.battletestedwa.com
Veteran Owned & Operated | King County & South King County, Washington